# Clinical Trial to Evaluate the Efficacy of RUTI® Against SARS-COV-2 Infection (COVID-19) in Healthcare Workers

> **NCT04453488** · PHASE3 · UNKNOWN · sponsor: **Fundació Institut Germans Trias i Pujol** · enrollment: 315 (estimated)

## Conditions studied

- Covid-19
- Sars-CoV2

## Interventions

- **BIOLOGICAL:** RUTI® vaccine
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT04453488
- **Lead sponsor:** Fundació Institut Germans Trias i Pujol
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07-30
- **Primary completion:** 2020-12
- **Final completion:** 2020-12
- **Target enrollment:** 315 (ESTIMATED)
- **Last updated:** 2020-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04453488

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04453488, "Clinical Trial to Evaluate the Efficacy of RUTI® Against SARS-COV-2 Infection (COVID-19) in Healthcare Workers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04453488. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*